Quanterix Corporation Acquires EMISSION iNC for $10 Million

The acquisition, valued at $10 million, is expected to be accretive to revenue and gross margins in 2026. Quanterix's ultrasensitive biomarker detection technology has been a trusted partner in the scientific community for almost two decades, and the acquisition aligns with its strategy to expand its technology stack towards higher multi-plex and multi-omic capabilities.